Acute myeloid leukemia therapy and the chosen people

Acute Myeloid Leukemia, Version 2.2013

(2017) Margaret R. O’Donnell et al.   Journal of the National Comprehensive Cancer Network

Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia

(2016) U Krug et al.   LEUKEMIA

Pragmatic Trials

(2016) Ian Ford et al.   NEW ENGLAND JOURNAL OF MEDICINE

Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States

(2015) Bruno C. Medeiros et al.   ANNALS OF HEMATOLOGY

FXa variants advance toward a therapy for bleeding

(2015) J. Emsley   BLOOD

Current challenges in clinical development of "targeted therapies": the case of acute myeloid leukemia

(2015) E. Estey et al.   BLOOD

Modernizing Eligibility Criteria for Molecularly Driven Trials

(2015) Edward S. Kim et al.   JOURNAL OF CLINICAL ONCOLOGY

Should criteria for inclusion in cancer clinical trials be expanded?

(2015) David E Gerber et al.   Journal of Comparative Effectiveness Research

Correlation between peripheral blood and bone marrow regarding FLT3-ITD and NPM1 mutational status in patients with acute myeloid leukemia

(2014) W.-G. Tong et al.   HAEMATOLOGICA

The NCI common toxicity criteria and treatment-associated mortality in acute myeloid leukemia

(2013) J. R. Veatch et al.   BLOOD

Declining rates of treatment-related mortality in patients with newly diagnosed AML given ‘intense’ induction regimens: a report from SWOG and MD Anderson

(2013) M Othus et al.   LEUKEMIA

Gemtuzumab Ozogamicin: Time to Resurrect?

(2012) Farhad Ravandi et al.   JOURNAL OF CLINICAL ONCOLOGY

Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment

(2011) Roland B. Walter et al.   JOURNAL OF CLINICAL ONCOLOGY

Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm

(2010) R. B. Walter et al.   BLOOD

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

(2009) H. Dohner et al.   BLOOD